News | 22 August 2026
Caplin Steriles gets US FDA Form 483 with 10 observations at Gummidipoondi unit
The company clarified that all 10 observations are strictly procedural in nature
The company clarified that all 10 observations are strictly procedural in nature
Sheltidin DS is a herbal throat-soothing spray designed to offer fast relief from dry and irritating coughs, sore throat, throat irritation
Saransh Chaudhary appointed Executive Director; Gurminder Singh Bedi joins as Independent Director, while Manu Chaudhary and Savita Gupta secure second terms
Operating income rises 21.2% to Rs. 186.1 crore as EBITDA margin expands to 17.9%; company targets Rs. 1,500 crore revenue and Rs. 200 crore+ net profit by FY30
The company announced the launch of 1,000 mg/10 mL and 5,000 mg/50 mL single-dose vials
A clinical study involving 138 Indian women aged 40-60 evaluated Fenavari at 300 mg and 500 mg doses
Company adds 246 net stores in Q1; customer footfall rises to 60 lakh as management targets 600-650 new outlets in FY27 and cash breakeven by Q4 FY27 or Q1 FY28
THIP Academy recognised for evidence-based vaccination education as platform expands courses on adult, paediatric and HPV vaccination
The trial met its primary endpoint of recurrence-free survival and a key secondary endpoint of distant metastasis-free survival, marking what the companies describe as the first positive Phase 3 readout
The company said corrective action was already initiated during the course of the inspection itself, and a formal response will be submitted to the US regulator within the stipulated timeline
The platform is designed to provide continuous, objective monitoring of Parkinson’s symptoms and treatment response, including bradykinesia, dyskinesia, tremor, sleep, motor fluctuations, gait and medication compliance
Visits UNICEF-supported programme in Maharashtra protecting children affected by seasonal migration through family- and community-based care
The agreement marks another step in Lupin’s strategy to expand its specialty ophthalmology business through VISUfarma, following the company’s strategic acquisition of the eye-care specialist
The company operates a CRO Plus model, combining clinical execution with strategic advisory and central laboratory capabilities
The partnership strengthens Mankind Pharma’s diabetes care and injectable portfolio, expanding its range of advanced insulin therapies for the Indian market
Six-day residential programme will provide researchers, policymakers and industry professionals with comprehensive training in vaccine development, clinical trials, regulatory approvals, manufacturing and quality compliance
The company also turned profitable at the standalone level, reporting PAT of Rs. 12 crore, against a loss of Rs. 3 crore in Q1 FY26
IQGEN-X Pharma is engaged in formulation development of oral solids, sterile injectables and ophthalmic solutions for regulated and semi-regulated markets.
The platform will facilitate continuous medical education, scientific discussions and exchange of real-world clinical experiences among healthcare professionals
Henlius will hold on to commercial rights within mainland China, Hong Kong, Macau and Taiwan, while Sandoz takes charge everywhere else globally
Subscribe To Our Newsletter & Stay Updated
